Scherman D, Jaudon P, Henry J P
Proc Natl Acad Sci U S A. 1983 Jan;80(2):584-8. doi: 10.1073/pnas.80.2.584.
[2-3H]Dihydrotetrabenazine (2-hydroxy-3-isobutyl-9, 10-dimethoxy-1,2,3,4,6,7-hexahydro-11b-H-benzo [a]-quinolizine), a derivative of the neuroleptic tetrabenazine, binds to the membrane of purified bovine chromaffin granules. Specific binding was characterized by Kd and Bmax values of 3.1 nM and 62 pmol/mg of membrane protein, respectively. It was reversible, with association and dissociation rate constants of 0.22 x 10(6) M-1 s-1 and 1.8 x 10(-3) s-1, respectively. Binding sites were present in extracts of medulla but not in corticoadrenal extracts; in the medulla they were restricted to chromaffin granule membranes, [2-3H]Dihydrotetrabenazine binding occurred on the catecholamine carrier of the chromaffin granule membrane because it was clearly correlated with inhibition of norepinephrine uptake. In addition, inhibitors and substrates of the uptake reaction displaced [2-3H]dihydrotetrabenazine from its binding sites, and their potency as displacers was qualitatively correlated with their IC50 or Km. These results suggest that use of [2-3H]dihydrotetrabenazine binding might be an interesting technique in the study of the vesicular monoamine carrier.
[2-³H]二氢丁苯那嗪(2-羟基-3-异丁基-9,10-二甲氧基-1,2,3,4,6,7-六氢-11b-H-苯并[a]喹嗪)是抗精神病药物丁苯那嗪的衍生物,可与纯化的牛嗜铬颗粒膜结合。特异性结合的特征在于,解离常数(Kd)和最大结合量(Bmax)分别为3.1 nM和62 pmol/mg膜蛋白。这种结合是可逆的,结合和解离速率常数分别为0.22×10⁶ M⁻¹ s⁻¹和1.8×10⁻³ s⁻¹。结合位点存在于髓质提取物中,但不存在于皮质肾上腺提取物中;在髓质中,它们仅限于嗜铬颗粒膜。[2-³H]二氢丁苯那嗪的结合发生在嗜铬颗粒膜的儿茶酚胺载体上,因为它与去甲肾上腺素摄取的抑制明显相关。此外,摄取反应的抑制剂和底物可将[2-³H]二氢丁苯那嗪从其结合位点上置换下来,并且它们作为置换剂的效力与其半数抑制浓度(IC50)或米氏常数(Km)在性质上相关。这些结果表明,利用[2-³H]二氢丁苯那嗪结合可能是研究囊泡单胺载体的一种有趣技术。